These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19911439)

  • 1. Proceedings of OMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology, Kananaskis Village, Alberta, Canada, May 27-31, 2008.
    J Rheumatol; 2009 Sep; 36(9):2045-121. PubMed ID: 19911439
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings of OMERACT 10, the International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials. May 4-8, 2010. Kota Kinabalu, Borneo.
    J Rheumatol; 2011 Jul; 38(7):1448-518. PubMed ID: 22263235
    [No Abstract]   [Full Text] [Related]  

  • 3. OMERACT 10--International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials.
    Brooks P; Boers M; Simon LS; Strand V; Tugwell P; Idzerda L
    J Rheumatol; 2011 Jul; 38(7):1450-51. PubMed ID: 21724714
    [No Abstract]   [Full Text] [Related]  

  • 4. OMERACT 11: international consensus conference on outcome measures in rheumatology.
    Simon LS; Strand V; Bingham CO; Singh JA
    J Rheumatol; 2014 Jan; 41(1):145-9. PubMed ID: 24382928
    [No Abstract]   [Full Text] [Related]  

  • 5. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
    Boers M; Kirwan JR; Wells G; Beaton D; Gossec L; d'Agostino MA; Conaghan PG; Bingham CO; Brooks P; Landewé R; March L; Simon LS; Singh JA; Strand V; Tugwell P
    J Clin Epidemiol; 2014 Jul; 67(7):745-53. PubMed ID: 24582946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updating the OMERACT filter at OMERACT 11.
    Kirwan JR; Boers M; Tugwell P
    J Rheumatol; 2014 May; 41(5):975-7. PubMed ID: 24788466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.
    Idzerda L; Rader T; Tugwell P; Boers M
    J Rheumatol; 2014 May; 41(5):986-93. PubMed ID: 24584917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OMERACT: an international initiative to improve outcome measurement in rheumatology.
    Boers M; Brooks P; Simon LS; Strand V; Tugwell P
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S10-3. PubMed ID: 16273779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OMERACT 6 brings new perspectives to rheumatology measurement research.
    Saag KG
    J Rheumatol; 2003 Apr; 30(4):639-41. PubMed ID: 12672177
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.
    Toupin-April K; Barton J; Fraenkel L; Li LC; Brooks P; De Wit M; Stacey D; Légaré F; Meara A; Shea B; Lyddiatt A; Hofstetter C; Gossec L; Christensen R; Scholte-Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Pohl C; Jull JE; Sivarajah S; Campbell W; Alten R; Karuranga S; Morgan E; Kaufman J; Hill S; Maxwell LJ; Welch V; Beaton D; El-Miedany Y; Tugwell PS
    J Rheumatol; 2017 Oct; 44(10):1544-1550. PubMed ID: 28765239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
    Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.
    Boers M; Idzerda L; Kirwan JR; Beaton D; Escorpizo R; Boonen A; Magasi S; Sinha I; Stucki G; Tugwell P
    J Rheumatol; 2014 May; 41(5):978-85. PubMed ID: 24584922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OMERACT 7. Proceedings of the International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials. May 8-12, 2004. Asilomar, California, USA.
    J Rheumatol; 2005 Dec; 32(12):2447-95. PubMed ID: 16331795
    [No Abstract]   [Full Text] [Related]  

  • 14. What has been the effect on trial outcome assessments of a decade of patient participation in OMERACT?
    de Wit MP; Abma TA; Koelewijn-van Loon MS; Collins S; Kirwan J
    J Rheumatol; 2014 Jan; 41(1):177-84. PubMed ID: 24128777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.
    Finger ME; Boonen A; Woodworth TG; Escorpizo R; Christensen R; Nielsen SM; Leong AL; Scholte Voshaar M; Flurey CA; Milman N; Verstappen SM; Alten R; Guillemin F; Kloppenburg M; Beaton DE; Tugwell PS; March LM; Furst DE; Pohl C
    J Rheumatol; 2017 Nov; 44(11):1734-1739. PubMed ID: 28461648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
    Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R
    J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OMERACT IV. Outcome Measures in Rheumatology. Cancún, Mexico, April 16-20, 1998.
    J Rheumatol; 1999 Feb; 26(2):459-507. PubMed ID: 10391752
    [No Abstract]   [Full Text] [Related]  

  • 18. Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development.
    Humphrey-Murto S; Crew R; Shea B; Bartlett SJ; March L; Tugwell P; Maxwell LJ; Beaton D; Grosskleg S; de Wit M
    J Rheumatol; 2019 Aug; 46(8):1041-1046. PubMed ID: 30770512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Stepwise Development of Patient Research Partnership: 14 Years' Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT).
    de Wit M; Kirwan JR; Tugwell P; Beaton D; Boers M; Brooks P; Collins S; Conaghan PG; D'Agostino MA; Hofstetter C; Hughes R; Leong A; Lyddiatt A; March L; May J; Montie P; Richards P; Simon LS; Singh JA; Strand V; Voshaar M; Bingham CO; Gossec L
    Patient; 2017 Apr; 10(2):141-152. PubMed ID: 27704486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets.
    Tunis SR; Maxwell LJ; Graham ID; Shea BJ; Beaton DE; Bingham CO; Brooks P; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March LM; Simon LS; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2017 Oct; 44(10):1551-1559. PubMed ID: 28765256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.